NRC Health (NASDAQ: NRC) Stock Competitors & Peer Comparison
See NRC's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NRC and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NRC | $25.86 | +1.49% | 572M | 31.54 | $0.82 | +2.51% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| TEM | $76.05 | +7.98% | 13.5B | -152.08 | -$0.50 | N/A |
| BTSGU | $212.10 | -1.95% | 13.4B | 129.05 | $1.71 | N/A |
| BTSG | $67.15 | +1.96% | 13.4B | 39.26 | $1.71 | N/A |
| HNGE | $115.76 | -0.19% | 9.3B | 61.90 | $1.87 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $103.63 | +0.16% | 8.6B | 24.20 | $4.28 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| DOCS | $32.51 | -2.02% | 5.8B | 21.25 | $1.53 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
NRC vs GEHCV Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas GEHCV's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to GEHCV's ROE of +0.20%. Regarding short-term risk, NRC is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for NRC.Check GEHCV's competition here
Tempus AI, Inc. (NASDAQ: TEM)
NRC vs TEM Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, TEM has a market cap of 13.5B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while TEM trades at $76.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas TEM's P/E ratio is -152.08. In terms of profitability, NRC's ROE is +1.03%, compared to TEM's ROE of -0.41%. Regarding short-term risk, NRC is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for NRC.Check TEM's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
NRC vs BTSGU Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, BTSGU has a market cap of 13.4B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while BTSGU trades at $212.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas BTSGU's P/E ratio is 129.05. In terms of profitability, NRC's ROE is +1.03%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, NRC is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for NRC.Check BTSGU's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
NRC vs BTSG Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, BTSG has a market cap of 13.4B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while BTSG trades at $67.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas BTSG's P/E ratio is 39.26. In terms of profitability, NRC's ROE is +1.03%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, NRC is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for NRC.Check BTSG's competition here
Hinge Health, Inc. (NYSE: HNGE)
NRC vs HNGE Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, HNGE has a market cap of 9.3B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while HNGE trades at $115.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas HNGE's P/E ratio is 61.90. In terms of profitability, NRC's ROE is +1.03%, compared to HNGE's ROE of +0.50%. Regarding short-term risk, NRC is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for NRC.Check HNGE's competition here
Signify Health, Inc. (NYSE: SGFY)
NRC vs SGFY Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas SGFY's P/E ratio is 70.91. In terms of profitability, NRC's ROE is +1.03%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, NRC is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
NRC vs HQY Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, HQY has a market cap of 8.6B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while HQY trades at $103.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas HQY's P/E ratio is 24.20. In terms of profitability, NRC's ROE is +1.03%, compared to HQY's ROE of +0.11%. Regarding short-term risk, NRC is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for NRC.Check HQY's competition here
R1 RCM Inc. (NASDAQ: RCM)
NRC vs RCM Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas RCM's P/E ratio is -102.21. In terms of profitability, NRC's ROE is +1.03%, compared to RCM's ROE of +0.00%. Regarding short-term risk, NRC is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for NRC.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
NRC vs DOCS Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, DOCS has a market cap of 5.8B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while DOCS trades at $32.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas DOCS's P/E ratio is 21.25. In terms of profitability, NRC's ROE is +1.03%, compared to DOCS's ROE of +0.15%. Regarding short-term risk, NRC is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for NRC.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
NRC vs WAY Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, WAY has a market cap of 5.5B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while WAY trades at $28.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas WAY's P/E ratio is 18.77. In terms of profitability, NRC's ROE is +1.03%, compared to WAY's ROE of +0.03%. Regarding short-term risk, NRC is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for NRC.Check WAY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
NRC vs HTFL Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, HTFL has a market cap of 4.6B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while HTFL trades at $52.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas HTFL's P/E ratio is -26.07. In terms of profitability, NRC's ROE is +1.03%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, NRC is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for NRC.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
NRC vs ONEM Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas ONEM's P/E ratio is -7.77. In terms of profitability, NRC's ROE is +1.03%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, NRC is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for NRC.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
NRC vs PRVA Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, PRVA has a market cap of 3.1B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while PRVA trades at $24.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas PRVA's P/E ratio is 116.33. In terms of profitability, NRC's ROE is +1.03%, compared to PRVA's ROE of +0.05%. Regarding short-term risk, NRC is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for NRC.Check PRVA's competition here
Certara, Inc. (NASDAQ: CERT)
NRC vs CERT Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, CERT has a market cap of 1.8B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while CERT trades at $12.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas CERT's P/E ratio is 30.07. In terms of profitability, NRC's ROE is +1.03%, compared to CERT's ROE of -0.06%. Regarding short-term risk, NRC is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for NRC.Check CERT's competition here
Omnicell, Inc. (NASDAQ: OMCL)
NRC vs OMCL Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, OMCL has a market cap of 1.7B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while OMCL trades at $37.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas OMCL's P/E ratio is 19.57. In terms of profitability, NRC's ROE is +1.03%, compared to OMCL's ROE of +0.04%. Regarding short-term risk, NRC is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for NRC.Check OMCL's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
NRC vs NXGN Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas NXGN's P/E ratio is -266.00. In terms of profitability, NRC's ROE is +1.03%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, NRC is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for NRC.Check NXGN's competition here
Teladoc Health, Inc. (NYSE: TDOC)
NRC vs TDOC Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, TDOC has a market cap of 1.6B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while TDOC trades at $8.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas TDOC's P/E ratio is -10.17. In terms of profitability, NRC's ROE is +1.03%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, NRC is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for NRC.Check TDOC's competition here
Agiliti, Inc. (NYSE: AGTI)
NRC vs AGTI Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas AGTI's P/E ratio is -71.79. In terms of profitability, NRC's ROE is +1.03%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, NRC is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for NRC.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
NRC vs GDRX Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while GDRX trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas GDRX's P/E ratio is 11.00. In terms of profitability, NRC's ROE is +1.03%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, NRC is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check GDRX's competition here
Omada Health (NASDAQ: OMDA)
NRC vs OMDA Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, OMDA has a market cap of 922.8M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while OMDA trades at $15.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas OMDA's P/E ratio is 65.54. In terms of profitability, NRC's ROE is +1.03%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, NRC is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for NRC.Check OMDA's competition here
HealthStream, Inc. (NASDAQ: HSTM)
NRC vs HSTM Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, HSTM has a market cap of 883M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while HSTM trades at $28.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas HSTM's P/E ratio is 40.08. In terms of profitability, NRC's ROE is +1.03%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, NRC is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for NRC.Check HSTM's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
NRC vs CCLDO Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas CCLDO's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to CCLDO's ROE of +0.24%. Regarding short-term risk, NRC is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CCLDO's competition here
Phreesia, Inc. (NYSE: PHR)
NRC vs PHR Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, PHR has a market cap of 783.6M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while PHR trades at $12.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas PHR's P/E ratio is 45.09. In terms of profitability, NRC's ROE is +1.03%, compared to PHR's ROE of +0.03%. Regarding short-term risk, NRC is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for NRC.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
NRC vs MPLN-WT Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, NRC is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MPLN-WT's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
NRC vs SOPH Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, SOPH has a market cap of 607.8M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while SOPH trades at $7.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas SOPH's P/E ratio is -6.43. In terms of profitability, NRC's ROE is +1.03%, compared to SOPH's ROE of -1.33%. Regarding short-term risk, NRC is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SOPH's competition here
Accolade, Inc. (NASDAQ: ACCD)
NRC vs ACCD Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas ACCD's P/E ratio is -3.08. In terms of profitability, NRC's ROE is +1.03%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, NRC is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for NRC.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
NRC vs SHCR Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas SHCR's P/E ratio is -3.76. In terms of profitability, NRC's ROE is +1.03%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, NRC is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
NRC vs EVH Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, EVH has a market cap of 514M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while EVH trades at $4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas EVH's P/E ratio is 35.15. In terms of profitability, NRC's ROE is +1.03%, compared to EVH's ROE of -1.30%. Regarding short-term risk, NRC is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check EVH's competition here
Carlsmed, Inc. (NASDAQ: CARL)
NRC vs CARL Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, CARL has a market cap of 396.4M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while CARL trades at $14.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas CARL's P/E ratio is -10.15. In terms of profitability, NRC's ROE is +1.03%, compared to CARL's ROE of -0.38%. Regarding short-term risk, NRC is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for NRC.Check CARL's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
NRC vs SLGCW Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, NRC's ROE is +1.03%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, NRC is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
NRC vs SLGC Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas SLGC's P/E ratio is -3.04. In terms of profitability, NRC's ROE is +1.03%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, NRC is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
NRC vs TBRG Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas TBRG's P/E ratio is 9.37. In terms of profitability, NRC's ROE is +1.03%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, NRC is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for NRC.Check TBRG's competition here
Claritev Corporation (NYSE: CTEV)
NRC vs CTEV Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, CTEV has a market cap of 386.7M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while CTEV trades at $22.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas CTEV's P/E ratio is -1.34. In terms of profitability, NRC's ROE is +1.03%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, NRC is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for NRC.Check CTEV's competition here
MultiPlan Corporation (NYSE: MPLN)
NRC vs MPLN Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas MPLN's P/E ratio is -0.23. In terms of profitability, NRC's ROE is +1.03%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, NRC is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MPLN's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
NRC vs TRHC Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas TRHC's P/E ratio is -4.27. In terms of profitability, NRC's ROE is +1.03%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, NRC is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for NRC.Check TRHC's competition here
So-Young International Inc. (NASDAQ: SY)
NRC vs SY Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, SY has a market cap of 268.1M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while SY trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas SY's P/E ratio is -6.21. In terms of profitability, NRC's ROE is +1.03%, compared to SY's ROE of -0.16%. Regarding short-term risk, NRC is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SY's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
NRC vs SMFR Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas SMFR's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, NRC is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
NRC vs SPOK Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, SPOK has a market cap of 245.2M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while SPOK trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas SPOK's P/E ratio is 13.19. In terms of profitability, NRC's ROE is +1.03%, compared to SPOK's ROE of +0.13%. Regarding short-term risk, NRC is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
NRC vs AMWL Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, AMWL has a market cap of 183.9M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while AMWL trades at $11.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas AMWL's P/E ratio is -2.71. In terms of profitability, NRC's ROE is +1.03%, compared to AMWL's ROE of -0.25%. Regarding short-term risk, NRC is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for NRC.Check AMWL's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
NRC vs OPRX Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, OPRX has a market cap of 164.8M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while OPRX trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas OPRX's P/E ratio is 8.03. In terms of profitability, NRC's ROE is +1.03%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, NRC is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check OPRX's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
NRC vs LFMDP Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, LFMDP has a market cap of 145.1M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while LFMDP trades at $21.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas LFMDP's P/E ratio is -655.78. In terms of profitability, NRC's ROE is +1.03%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, NRC is less volatile compared to LFMDP. This indicates lower risk in terms of short-term price fluctuations for NRC.Check LFMDP's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
NRC vs CPSI Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas CPSI's P/E ratio is -183.80. In terms of profitability, NRC's ROE is +1.03%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, NRC is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for NRC.Check CPSI's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
NRC vs DH Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, DH has a market cap of 121.7M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while DH trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas DH's P/E ratio is 4.38. In terms of profitability, NRC's ROE is +1.03%, compared to DH's ROE of -0.83%. Regarding short-term risk, NRC is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check DH's competition here
Augmedix, Inc. (NASDAQ: AUGX)
NRC vs AUGX Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas AUGX's P/E ratio is -4.99. In terms of profitability, NRC's ROE is +1.03%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, NRC is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for NRC.Check AUGX's competition here
LifeMD, Inc. (NASDAQ: LFMD)
NRC vs LFMD Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, LFMD has a market cap of 114.1M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while LFMD trades at $2.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas LFMD's P/E ratio is -4.73. In terms of profitability, NRC's ROE is +1.03%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, NRC is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for NRC.Check LFMD's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
NRC vs HCAT Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, HCAT has a market cap of 110.6M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while HCAT trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas HCAT's P/E ratio is 7.35. In terms of profitability, NRC's ROE is +1.03%, compared to HCAT's ROE of -1.28%. Regarding short-term risk, NRC is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for NRC.Check HCAT's competition here
CareCloud, Inc. (NASDAQ: CCLD)
NRC vs CCLD Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, CCLD has a market cap of 96.9M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while CCLD trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas CCLD's P/E ratio is 8.77. In terms of profitability, NRC's ROE is +1.03%, compared to CCLD's ROE of +0.24%. Regarding short-term risk, NRC is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for NRC.Check CCLD's competition here
Forian Inc. (NASDAQ: FORA)
NRC vs FORA Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas FORA's P/E ratio is -24.11. In terms of profitability, NRC's ROE is +1.03%, compared to FORA's ROE of -0.17%. Regarding short-term risk, NRC is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for NRC.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
NRC vs CCLDP Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas CCLDP's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to CCLDP's ROE of +0.24%. Regarding short-term risk, NRC is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
NRC vs SNCE Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas SNCE's P/E ratio is -0.27. In terms of profitability, NRC's ROE is +1.03%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, NRC is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
NRC vs AKLI Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas AKLI's P/E ratio is -0.71. In terms of profitability, NRC's ROE is +1.03%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, NRC is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for NRC.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
NRC vs SHLT Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas SHLT's P/E ratio is -3.87. In terms of profitability, NRC's ROE is +1.03%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, NRC is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
NRC vs SHCRW Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, NRC's ROE is +1.03%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, NRC is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMD)
NRC vs ONMD Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, ONMD has a market cap of 29.7M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while ONMD trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas ONMD's P/E ratio is -31.87. In terms of profitability, NRC's ROE is +1.03%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, NRC is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ONMD's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
NRC vs STRM Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas STRM's P/E ratio is -2.40. In terms of profitability, NRC's ROE is +1.03%, compared to STRM's ROE of -0.65%. Regarding short-term risk, NRC is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for NRC.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
NRC vs RNLX Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas RNLX's P/E ratio is -0.33. In terms of profitability, NRC's ROE is +1.03%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, NRC is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
NRC vs LIFW Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas LIFW's P/E ratio is -0.02. In terms of profitability, NRC's ROE is +1.03%, compared to LIFW's ROE of +0.81%. Regarding short-term risk, NRC is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check LIFW's competition here
SCWorx Corp. (NASDAQ: WORX)
NRC vs WORX Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, WORX has a market cap of 20.6M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while WORX trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas WORX's P/E ratio is -1.50. In terms of profitability, NRC's ROE is +1.03%, compared to WORX's ROE of -0.35%. Regarding short-term risk, NRC is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check WORX's competition here
Babylon Holdings Limited (NYSE: BBLN)
NRC vs BBLN Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas BBLN's P/E ratio is -0.04. In terms of profitability, NRC's ROE is +1.03%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, NRC is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for NRC.Check BBLN's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
NRC vs ONMDW Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, ONMDW has a market cap of 9.9M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while ONMDW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas ONMDW's P/E ratio is -0.07. In terms of profitability, NRC's ROE is +1.03%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, NRC is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ONMDW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
NRC vs ETAO Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas ETAO's P/E ratio is -0.01. In terms of profitability, NRC's ROE is +1.03%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, NRC is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
NRC vs BFRG Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, BFRG has a market cap of 9.6M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while BFRG trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas BFRG's P/E ratio is -1.13. In terms of profitability, NRC's ROE is +1.03%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, NRC is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for NRC.Check BFRG's competition here
UpHealth, Inc. (NYSE: UPH-WT)
NRC vs UPH-WT Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to UPH-WT's ROE of -0.72%. Regarding short-term risk, NRC is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for NRC.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
NRC vs UPH Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas UPH's P/E ratio is -0.07. In terms of profitability, NRC's ROE is +1.03%, compared to UPH's ROE of -1.05%. Regarding short-term risk, NRC is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check UPH's competition here
Aclarion, Inc. (NASDAQ: ACON)
NRC vs ACON Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, ACON has a market cap of 4.9M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while ACON trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas ACON's P/E ratio is -0.19. In terms of profitability, NRC's ROE is +1.03%, compared to ACON's ROE of -0.63%. Regarding short-term risk, NRC is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ACON's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
NRC vs MGRX Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, MGRX has a market cap of 4.3M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while MGRX trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas MGRX's P/E ratio is -0.14. In terms of profitability, NRC's ROE is +1.03%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, NRC is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
NRC vs PEARW Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas PEARW's P/E ratio is -0.00. In terms of profitability, NRC's ROE is +1.03%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, NRC is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
NRC vs PEAR Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas PEAR's P/E ratio is -0.08. In terms of profitability, NRC's ROE is +1.03%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, NRC is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for NRC.Check PEAR's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
NRC vs HCTI Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, HCTI has a market cap of 2.8M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while HCTI trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas HCTI's P/E ratio is -0.47. In terms of profitability, NRC's ROE is +1.03%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, NRC is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for NRC.Check HCTI's competition here
Ontrak, Inc. (NASDAQ: OTRK)
NRC vs OTRK Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas OTRK's P/E ratio is -0.02. In terms of profitability, NRC's ROE is +1.03%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, NRC is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for NRC.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
NRC vs CMAX Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas CMAX's P/E ratio is -0.00. In terms of profitability, NRC's ROE is +1.03%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, NRC is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CMAX's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
NRC vs BFRGW Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, BFRGW has a market cap of 1.3M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while BFRGW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas BFRGW's P/E ratio is -0.22. In terms of profitability, NRC's ROE is +1.03%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, NRC is more volatile compared to BFRGW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check BFRGW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
NRC vs LIFWZ Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to LIFWZ's ROE of +0.81%. Regarding short-term risk, NRC is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for NRC.Check LIFWZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
NRC vs VSEE Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, VSEE has a market cap of 931.2K. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while VSEE trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas VSEE's P/E ratio is -2.58. In terms of profitability, NRC's ROE is +1.03%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, NRC is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for NRC.Check VSEE's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
NRC vs VSEEW Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, NRC's ROE is +1.03%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, NRC is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
NRC vs MSPRZ Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to MSPRZ's ROE of +0.81%. Regarding short-term risk, NRC is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERNW)
NRC vs KERNW Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas KERNW's P/E ratio is -0.00. In terms of profitability, NRC's ROE is +1.03%, compared to KERNW's ROE of -0.02%. Regarding short-term risk, NRC is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
NRC vs KERN Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas KERN's P/E ratio is -0.01. In terms of profitability, NRC's ROE is +1.03%, compared to KERN's ROE of -0.02%. Regarding short-term risk, NRC is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for NRC.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
NRC vs LIFWW Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas LIFWW's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to LIFWW's ROE of +0.81%. Regarding short-term risk, NRC is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
NRC vs CMAXW Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas CMAXW's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, NRC is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
NRC vs ZCMD Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, ZCMD has a market cap of 16.6K. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while ZCMD trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, NRC's ROE is +1.03%, compared to ZCMD's ROE of -0.54%. Regarding short-term risk, NRC is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
NRC vs ACONW Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, ACONW has a market cap of 14.3K. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas ACONW's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to ACONW's ROE of -0.63%. Regarding short-term risk, NRC is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check ACONW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
NRC vs MSPRV Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas MSPRV's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to MSPRV's ROE of N/A. Regarding short-term risk, NRC is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBC)
NRC vs MTBC Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas MTBC's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to MTBC's ROE of +0.30%. Regarding short-term risk, NRC is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MTBC's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
NRC vs MTBCP Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas MTBCP's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to MTBCP's ROE of +0.24%. Regarding short-term risk, NRC is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for NRC.Check MTBCP's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
NRC vs NAVA Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas NAVA's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, NRC is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for NRC.Check NAVA's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
NRC vs AFFX Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas AFFX's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, NRC is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for NRC.Check AFFX's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
NRC vs CHNG Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas CHNG's P/E ratio is -152.72. In terms of profitability, NRC's ROE is +1.03%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, NRC is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CHNG's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
NRC vs KURIU Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas KURIU's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, NRC is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for NRC.Check KURIU's competition here
Cerner Corporation (NASDAQ: CERN)
NRC vs CERN Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, CERN has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas CERN's P/E ratio is 55.84. In terms of profitability, NRC's ROE is +1.03%, compared to CERN's ROE of +0.14%. Regarding short-term risk, NRC is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CERN's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
NRC vs CHNGU Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas CHNGU's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, NRC is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CHNGU's competition here
Castlight Health, Inc. (NYSE: CSLT)
NRC vs CSLT Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas CSLT's P/E ratio is -37.27. In terms of profitability, NRC's ROE is +1.03%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, NRC is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CSLT's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
NRC vs IMS Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, IMS has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas IMS's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to IMS's ROE of +0.27%. Regarding short-term risk, NRC is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for NRC.Check IMS's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
NRC vs SMFRW Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas SMFRW's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, NRC is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SMFRW's competition here
NantHealth, Inc. (NASDAQ: NH)
NRC vs NH Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, NH has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas NH's P/E ratio is -0.12. In terms of profitability, NRC's ROE is +1.03%, compared to NH's ROE of +0.35%. Regarding short-term risk, NRC is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check NH's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
NRC vs MTBCO Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas MTBCO's P/E ratio is N/A. In terms of profitability, NRC's ROE is +1.03%, compared to MTBCO's ROE of +0.24%. Regarding short-term risk, NRC is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for NRC.Check MTBCO's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
NRC vs CNVY Comparison November 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 572M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, NRC is priced at $25.86 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 31.54, whereas CNVY's P/E ratio is -71.50. In terms of profitability, NRC's ROE is +1.03%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, NRC is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CNVY's competition here